Basic Information
Acerta Pharma is dedicated to developing covalent binding technology solutions to create cancer treatments, and the company develops drugs for oncology and autoimmune disease research.
Acerta Pharma
United States of America
51~100 people
January 01, 2013
info@acerta-pharma.com
Enterprise Profile
Industrial Sector
Concept